Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka

Sajani Dias, Shirley Longacre, Ananias A. Escalante, Preethi V. Udagama-Randeniya

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Extensive polymorphism in the genes encoding for surface antigens of Plasmodium falciparum and Plasmodium vivax has been a serious impediment for malaria vaccine development. One such antigen is the merozoite surface protein-1 (MSP-1). The MSP-1 precursor after proteolytic cleavage generates a C-terminal fragment of 42kDa (MSP-142), which subsequently produces 33kDa (MSP-133) and 19kDa (MSP-119) fragments. Since MSP-142 is currently being considered as a candidate for vaccine development against blood stage malaria it is important to catalogue the existing diversity in this antigen in natural P. vivax infections. Here we investigated the level of genetic diversity in the PvMSP-142 gene fragment in 95 single clone P. vivax infections in Sri Lanka. We observed that the PvMSP-119 fragment was highly conserved among these samples, whereas the PvMSP-133 fragment exhibited extensive diversity with 39 polymorphic amino acid positions (corresponding to 27 haplotypes, 19 of which were unique to Sri Lanka). Of these 27 PvMSP-142 haplotypes, 24 belonged to hypervariable region (HVR) T1-T7 types, while 3 haplotypes were generated by interallelic recombination between T1/T3 (HVRT8-T9) and T2/T3 (HVRT10). In addition, we analysed 107 PvMSP-142 sequences (corresponding to 62 haplotypes, H28 to H89) deposited in the NCBI GenBank database from other regions of the world. Seventy-four of these correspond to 9 of the 10 HVR types (HVR-T7 was unique to Sri Lanka). Two novel HVR types, T11 and T12, with a double recombination between HVR-T1/T3 and HVRT6/T2, were derived from South America and Thailand, respectively. T cell epitope polymorphism arising due to non-synonymous substitutions in PvMSP-133 may result in differential binding of the polymorphic peptides to class II MHC alleles, inducing different host immune responses. In conclusion, under low transmission and unstable malaria conditions prevalent in Sri Lanka, extensive allelic polymorphism was evident at PvMSP-133 due to recombination, mutation, and balancing selection. In contrast, PvMSP-119 is highly conserved, greatly enhancing its suitability as a malaria vaccine candidate.

Original languageEnglish (US)
Pages (from-to)145-156
Number of pages12
JournalInfection, Genetics and Evolution
Volume11
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Merozoite Surface Protein 1
Plasmodium vivax
genetic recombination
Sri Lanka
merozoites
surface proteins
Haplotypes
Genetic Recombination
recombination
Malaria
haplotypes
triiodothyronine
malaria
Malaria Vaccines
genetic variation
protein
vaccine development
vaccine
genetic polymorphism
antigen

Keywords

  • Genetic diversity
  • Malaria
  • Merozoite surface protein-1
  • Plasmodium vivax
  • Sri Lanka

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Genetics
  • Molecular Biology
  • Microbiology
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka. / Dias, Sajani; Longacre, Shirley; Escalante, Ananias A.; Udagama-Randeniya, Preethi V.

In: Infection, Genetics and Evolution, Vol. 11, No. 1, 01.2011, p. 145-156.

Research output: Contribution to journalArticle

Dias, Sajani ; Longacre, Shirley ; Escalante, Ananias A. ; Udagama-Randeniya, Preethi V. / Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka. In: Infection, Genetics and Evolution. 2011 ; Vol. 11, No. 1. pp. 145-156.
@article{3e16c2b646044d53863530452ac098a4,
title = "Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka",
abstract = "Extensive polymorphism in the genes encoding for surface antigens of Plasmodium falciparum and Plasmodium vivax has been a serious impediment for malaria vaccine development. One such antigen is the merozoite surface protein-1 (MSP-1). The MSP-1 precursor after proteolytic cleavage generates a C-terminal fragment of 42kDa (MSP-142), which subsequently produces 33kDa (MSP-133) and 19kDa (MSP-119) fragments. Since MSP-142 is currently being considered as a candidate for vaccine development against blood stage malaria it is important to catalogue the existing diversity in this antigen in natural P. vivax infections. Here we investigated the level of genetic diversity in the PvMSP-142 gene fragment in 95 single clone P. vivax infections in Sri Lanka. We observed that the PvMSP-119 fragment was highly conserved among these samples, whereas the PvMSP-133 fragment exhibited extensive diversity with 39 polymorphic amino acid positions (corresponding to 27 haplotypes, 19 of which were unique to Sri Lanka). Of these 27 PvMSP-142 haplotypes, 24 belonged to hypervariable region (HVR) T1-T7 types, while 3 haplotypes were generated by interallelic recombination between T1/T3 (HVRT8-T9) and T2/T3 (HVRT10). In addition, we analysed 107 PvMSP-142 sequences (corresponding to 62 haplotypes, H28 to H89) deposited in the NCBI GenBank database from other regions of the world. Seventy-four of these correspond to 9 of the 10 HVR types (HVR-T7 was unique to Sri Lanka). Two novel HVR types, T11 and T12, with a double recombination between HVR-T1/T3 and HVRT6/T2, were derived from South America and Thailand, respectively. T cell epitope polymorphism arising due to non-synonymous substitutions in PvMSP-133 may result in differential binding of the polymorphic peptides to class II MHC alleles, inducing different host immune responses. In conclusion, under low transmission and unstable malaria conditions prevalent in Sri Lanka, extensive allelic polymorphism was evident at PvMSP-133 due to recombination, mutation, and balancing selection. In contrast, PvMSP-119 is highly conserved, greatly enhancing its suitability as a malaria vaccine candidate.",
keywords = "Genetic diversity, Malaria, Merozoite surface protein-1, Plasmodium vivax, Sri Lanka",
author = "Sajani Dias and Shirley Longacre and Escalante, {Ananias A.} and Udagama-Randeniya, {Preethi V.}",
year = "2011",
month = "1",
doi = "10.1016/j.meegid.2010.09.007",
language = "English (US)",
volume = "11",
pages = "145--156",
journal = "Infection, Genetics and Evolution",
issn = "1567-1348",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka

AU - Dias, Sajani

AU - Longacre, Shirley

AU - Escalante, Ananias A.

AU - Udagama-Randeniya, Preethi V.

PY - 2011/1

Y1 - 2011/1

N2 - Extensive polymorphism in the genes encoding for surface antigens of Plasmodium falciparum and Plasmodium vivax has been a serious impediment for malaria vaccine development. One such antigen is the merozoite surface protein-1 (MSP-1). The MSP-1 precursor after proteolytic cleavage generates a C-terminal fragment of 42kDa (MSP-142), which subsequently produces 33kDa (MSP-133) and 19kDa (MSP-119) fragments. Since MSP-142 is currently being considered as a candidate for vaccine development against blood stage malaria it is important to catalogue the existing diversity in this antigen in natural P. vivax infections. Here we investigated the level of genetic diversity in the PvMSP-142 gene fragment in 95 single clone P. vivax infections in Sri Lanka. We observed that the PvMSP-119 fragment was highly conserved among these samples, whereas the PvMSP-133 fragment exhibited extensive diversity with 39 polymorphic amino acid positions (corresponding to 27 haplotypes, 19 of which were unique to Sri Lanka). Of these 27 PvMSP-142 haplotypes, 24 belonged to hypervariable region (HVR) T1-T7 types, while 3 haplotypes were generated by interallelic recombination between T1/T3 (HVRT8-T9) and T2/T3 (HVRT10). In addition, we analysed 107 PvMSP-142 sequences (corresponding to 62 haplotypes, H28 to H89) deposited in the NCBI GenBank database from other regions of the world. Seventy-four of these correspond to 9 of the 10 HVR types (HVR-T7 was unique to Sri Lanka). Two novel HVR types, T11 and T12, with a double recombination between HVR-T1/T3 and HVRT6/T2, were derived from South America and Thailand, respectively. T cell epitope polymorphism arising due to non-synonymous substitutions in PvMSP-133 may result in differential binding of the polymorphic peptides to class II MHC alleles, inducing different host immune responses. In conclusion, under low transmission and unstable malaria conditions prevalent in Sri Lanka, extensive allelic polymorphism was evident at PvMSP-133 due to recombination, mutation, and balancing selection. In contrast, PvMSP-119 is highly conserved, greatly enhancing its suitability as a malaria vaccine candidate.

AB - Extensive polymorphism in the genes encoding for surface antigens of Plasmodium falciparum and Plasmodium vivax has been a serious impediment for malaria vaccine development. One such antigen is the merozoite surface protein-1 (MSP-1). The MSP-1 precursor after proteolytic cleavage generates a C-terminal fragment of 42kDa (MSP-142), which subsequently produces 33kDa (MSP-133) and 19kDa (MSP-119) fragments. Since MSP-142 is currently being considered as a candidate for vaccine development against blood stage malaria it is important to catalogue the existing diversity in this antigen in natural P. vivax infections. Here we investigated the level of genetic diversity in the PvMSP-142 gene fragment in 95 single clone P. vivax infections in Sri Lanka. We observed that the PvMSP-119 fragment was highly conserved among these samples, whereas the PvMSP-133 fragment exhibited extensive diversity with 39 polymorphic amino acid positions (corresponding to 27 haplotypes, 19 of which were unique to Sri Lanka). Of these 27 PvMSP-142 haplotypes, 24 belonged to hypervariable region (HVR) T1-T7 types, while 3 haplotypes were generated by interallelic recombination between T1/T3 (HVRT8-T9) and T2/T3 (HVRT10). In addition, we analysed 107 PvMSP-142 sequences (corresponding to 62 haplotypes, H28 to H89) deposited in the NCBI GenBank database from other regions of the world. Seventy-four of these correspond to 9 of the 10 HVR types (HVR-T7 was unique to Sri Lanka). Two novel HVR types, T11 and T12, with a double recombination between HVR-T1/T3 and HVRT6/T2, were derived from South America and Thailand, respectively. T cell epitope polymorphism arising due to non-synonymous substitutions in PvMSP-133 may result in differential binding of the polymorphic peptides to class II MHC alleles, inducing different host immune responses. In conclusion, under low transmission and unstable malaria conditions prevalent in Sri Lanka, extensive allelic polymorphism was evident at PvMSP-133 due to recombination, mutation, and balancing selection. In contrast, PvMSP-119 is highly conserved, greatly enhancing its suitability as a malaria vaccine candidate.

KW - Genetic diversity

KW - Malaria

KW - Merozoite surface protein-1

KW - Plasmodium vivax

KW - Sri Lanka

UR - http://www.scopus.com/inward/record.url?scp=78650235349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650235349&partnerID=8YFLogxK

U2 - 10.1016/j.meegid.2010.09.007

DO - 10.1016/j.meegid.2010.09.007

M3 - Article

C2 - 20933611

AN - SCOPUS:78650235349

VL - 11

SP - 145

EP - 156

JO - Infection, Genetics and Evolution

JF - Infection, Genetics and Evolution

SN - 1567-1348

IS - 1

ER -